James P. Mackin - 20 Feb 2024 Form 4 Insider Report for ARTIVION, INC. (AORT)

Role
President & CEO
Signature
/s/ James P. Mackin
Issuer symbol
AORT
Transactions as of
20 Feb 2024
Net transactions value
-$393,450
Form type
4
Filing time
22 Feb 2024, 17:08:07 UTC
Previous filing
03 Mar 2023
Next filing
26 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $965,368 +59,225 +11% $16.30 611,105 20 Feb 2024 Direct F1
transaction AORT Common Stock Sale $1,116,516 -59,225 -9.7% $18.85 551,880 20 Feb 2024 Direct F1, F2
transaction AORT Common Stock Sale $190,310 -10,088 -1.8% $18.86 541,792 20 Feb 2024 Direct F3
transaction AORT Common Stock Sale $51,992 -2,756 -0.51% $18.86 539,036 20 Feb 2024 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Option(Right to Buy) Options Exercise $0 -59,225 -100% $0.000000* 0 20 Feb 2024 Common Stock 59,225 $16.30 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 11, 2023.
F2 Reflects weighted average price. Range of prices were between $18.05 to $19.295. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 These shares were sold upon the vesting of Restricted Stock awards to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
F4 These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.
F5 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 02/21/2018.